Two students from UC's top-ranked design programs have applied for a provisional patent on their design and prototype of a prescription-medicine pill bottle for the blind and visually impaired - an innovation that could benefit millions of users. It's easy to see that University of Cincinnati design students Alex Broerman ...

It's easy to see that University of Cincinnati design students Alex Broerman and Ashley Ma are on to something with their new design and prototype for a prescription-medicine pill bottle that better serves the needs of the blind and visually impaired by means of a simple and inexpensive innovation. ...

(University of Cincinnati) Two students from UC's top-ranked design programs have applied for a provisional patent on their design and prototype of a prescription-medicine pill bottle for the blind and visually impaired -- an innovation that could benefit millions of users.

By Steven Reinberg HealthDay Reporter THURSDAY, May 10 (HealthDay News) -- Some women using hormonal contraceptives other than birth control pills may have an increased risk for serious blood clots, Danish researchers report. These alternate hormone-releasing birth control methods include skin patches, ...

On Thursday, a panel of outside experts that advises the US Food and Drug Administration (FDA) voted to support approval of the daily pill Truvada to prevent HIV in healthy people. The FDA is not obliged to follow the advice of its Antiviral Drugs Advisory Committee, but ...

�A systematic review of 35 years of data published online in Europe's leading reproductive medicine journal Human Reproduction shows that intrauterine devices (IUDs), commonly known as a 'coil' should be routinely used as emergency contraception, given that their failure rate is less than one per thousand and because it has ...

By Randy Dotinga HealthDay Reporter WEDNESDAY, May 9 (HealthDay News) -- U.S. Food and Drug Administration advisers will meet Thursday to decide whether to endorse the use of the drug Truvada as a means to help prevent HIV infection in people at high ...

Pfizer is waiting for the Food and Drug Administration to approve its new pill for rheumatoid arthritis (RA) - the first oral biologic for treating this ailment.

A study in the May issue of the Cell Press journal Cell Metabolism appears to offer vindication for an approach to anti-aging drugs that has been at the center of heated scientific debate in recent years. The new findings show for the first time that the metabolic benefits of the ...

According to an NHS report girls as young as 13 should be given the contraceptive pill without having to see a doctor. Normally girls and women can only go on the Pill once they have undergone a thorough consultation with a GP or nurse as it can cause side effects ...

A once daily pill to prevent HIV infection could significantly reduce the spread of the AIDS-causing virus. However it would only be cost-effective if limited to men at very high risk for HIV infection, according to a new study.

Stanford University researchers have concluded that a once a day pill designed to prevent the spread of HIV could prove cost effective for high risk members of the population. The drug, known as tenofovir-emtricitabine, reduces the risk of HIV infection by nearly fifty percent in a 2010 clinical trial, ...